Characteristics and Absolute Survival of Metastatic Colorectal Cancer Patients Treated With Biologics: A Real-World Data Analysis From Three European Countries

Introduction: Biologics were approved for the treatment of advanced colorectal cancer (CRC) based on favorable benefit-risk-assessments from randomized controlled trials (RCTs), but evidence on their use in the real-world setting is scarce. Based on descriptive analyses we therefore aimed to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Oppelt, Katja A., Kuiper, Josephina G., Ingrasciotta, Ylenia, Ientile, Valentina, Herings, Ron M. C., Tari, Michele, Trifirò, Gianluca, Haug, Ulrike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973261/
https://www.ncbi.nlm.nih.gov/pubmed/33747950
http://dx.doi.org/10.3389/fonc.2021.630456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973261/
https://www.ncbi.nlm.nih.gov/pubmed/33747950
http://dx.doi.org/10.3389/fonc.2021.630456

Ejemplares similares